key: cord-1039146-kjpg7djb
authors: Häring, Clio; Schroeder, Josefine; Löffler, Bettina; Engert, Beatrice; Ehrhardt, Christina
title: The local anaesthetic procaine prodrugs ProcCluster® and Procaine-hydrochloride impair SARS-CoV-2 replication in vitro
date: 2021-06-07
journal: bioRxiv
DOI: 10.1101/2021.06.07.447335
sha: 19f693eaa262f3ac76e0a580874d88bd6db62bcd
doc_id: 1039146
cord_uid: kjpg7djb

The SARS-CoV-2 pandemic has had the world in suspense for more than a year. Even if more and more vaccines are approved there is still an urgent need for efficient antiviral treatment strategies. Here, we present data on the inhibitory effect of the local anaesthetic procaine, especially the prodrugs ProcCluster® and Procaine-hydrochloride on SARS-CoV-2 infection in vitro. Remarkably, similar effects could be shown on the replication of influenza A viruses in cell culture systems. Since the active ingredient procaine is well-tolerated and already used in the clinics for anaesthetic purposes, the further investigation of this substance could enable its reuse in antiviral therapy, including SARS-CoV-2.

The ongoing spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV- Here, we investigated if procaine, which is usually used as a local anaesthetic, represents a 59 potential candidate for further antiviral studies. Local anaesthetics are described to exhibit anti- as Procainum-hydrogen-carbonate (ProcHHCO3 * NaCl), which was manufactured and 68 supplied by inflamed pharma GmbH (Jena). PC is based on procaine, an ester-type local 69 anaesthetic, which is stabilized by the mineral salt enhancing the bioavailability. Since 2008 70 PC has been used in Germany for the preparation of prescription drugs, which are administered 71 orally and dermally. Since 2012, the license to manufacture parenteral drugs as part of the 72 4 permit-free inhouse production exists ( §13 2b AMG). Similarly, Procaine-hydrochloride 73 (ProcHCl) is a prodrug of procaine and is administered parenterally. 74

Thus, we analyzed if procaine, in particular PC and ProcHCl exhibit antiviral effects on SARS-75

CoV-2 and influenza A virus (IAV) infection in vitro. 76

The potential antiviral effect of procaine on SARS-CoV-2 ( CoV-2 spike protein levels in a concentration-dependent manner, as detected by western-blot 103 analysis ( Figure 1D ). Correlating, a decreased production of the viral matrix 1 protein (M1) 104 could be observed in IAV-infected A549 cells ( Figure S1D ). In order to visualize the extent of 105

of procaine, immunofluorescence microscopy studies were performed at 24 h p.i. (Figure 1E In summary, our data show that PC as well as ProcHCl have antiviral activity against SARS-120

CoV-2 and IAV infection and also affect virus-induced cytokine expression. As mentioned 121 above the procaine has a variety of properties. Future studies need to elucidate the procaine-, 122 and in particular the PC-and ProcHCl-mediated effects on virus-induced cellular mechanisms. 123 The mRNA synthesis of SARS-CoV-2 (N1), cellular IFN-b, IL-6 and IP-10 were quantified by 133 qRT-PCR. Data represent the mean + SD of three (A, B, F) or four (C) independent 134 experiments, including two technical samples (*p < 0.05; **p < 0.01; *** p < 0.001; **** p < 135 0.0001). 136

Coronavirus Infections-More Than Just the Common 154 Cold

Early postmortem mapping of 156 SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage

The Contribution of Endothelial Dysfunction in 159

Systemic Injury Subsequent to SARS-Cov-2 Infection

COVID-19 update: The race to therapeutic 162 development

Local anaesthesia prevents acute inflammatory 164 changes in neuropeptide messenger RNA expression in rat dorsal root ganglia neurons

The entry of Junin virus into Vero cells. 167 Arch Virol

Inhibition of adsorption of West-Nile and herpes simplex viruses 169 by procaine

Time-dependent inhibition of G protein-171 coupled receptor signaling by local anesthetics

Procaine Inhibits the Proliferation and Migration of Colon 174

Cancer Cells Through Inactivation of the ERK/MAPK/FAK Pathways by Regulation of 175 RhoA

The Two Sides of the Same Coin-Influenza 177

Virus and Intracellular Signal Transduction. Cold Spring Harb Perspect Med

Phosphoproteomic-based kinase profiling 180 early in influenza virus infection identifies GRK2 as antiviral drug target

SARS-CoV-2 causes severe epithelial 183 inflammation and barrier dysfunction

Vemurafenib Limits Influenza A Virus 185 Propagation by Targeting Multiple Signaling Pathways

We thank Stefanie Kynast, Jessica Lux and Heike Urban for excellent technical support. 138

The authors have read the journal´s policy and have the following conflicts: Beatrice Engert is 140 employed by the inflamed pharma GmbH (Jena). This does not alter the authors´ adherence to 141 scientific policies on sharing data and material. 142